Skip to content

PDT As An Adjunct To SRP In The Management of Chronic Periodontitis

Photodynamic Therapy Using Zinc Oxide Photosensitizer As An Adjunct To Scaling And Root Planing In The Management Of Chronic Periodontitis - A Split Mouth Double Blind Randomized Controlled Clinical Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03770819
Enrollment
16
Registered
2018-12-10
Start date
2019-03-31
Completion date
2019-06-30
Last updated
2019-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Periodontitis

Brief summary

The present study aims to evaluate photodynamic therapy (PDT) using Zinc oxide as a photosensitizer as an adjunct to scaling and root planing (SRP) in the management of chronic periodontitis.

Detailed description

Following full mouth SRP, each quadrant will be randomly assigned by simple randomization using a computer generated randomization technique into one of the following four treatment modalities. Group 1 (control) - Application of placebo gel followed by sham PDT (Directing the Light cure device without turning on the light beam). Group 2 -Application of Zinc oxide gel followed by sham PDT. Group 3 - Application of placebo gel followed by PDT. Group 4 - Application of Zinc oxide gel followed by PDT. The procedure mentioned for each group will be performed on all periodontal pockets in the assigned quadrant at baseline, end of 1 week and 1 month from the first session. Clinical parameters and microbial profile will be recorded at baseline (before commencement of Periodontal treatment), end of 1 month and end of 3 months following periodontal treatment. Zinc oxide gel/placebo gel will be placed into the periodontal pockets using a blunt cannula ensuring that starting from the bottom, it completely fills the periodontal pockets. The gel will be retained in the pocket for 5 minutes. The perio tip will be attached to the hand piece of the light cure unit (Wavelength: 420-480nm. Light power: 1200mw/cm2 in continuous mode) and light will be activated for 60 seconds. Following this, the pockets will be irrigated with normal saline solution (0.9%Sodium chloride).

Interventions

PROCEDUREPhotodynamic therapy

Zinc oxide gel/placebo gel will be placed into the periodontal pockets using a blunt cannula ensuring that starting from the bottom, it completely fills the periodontal pockets. The gel will be retained in the pocket for 5 minutes. The perio tip will be attached to the hand piece of the light cure unit (Wavelength: 420-480nm. Light power: 1200mw/cm2 in continuous mode) and light will be activated for 60 seconds. Following this, the pockets will be irrigated with normal saline solution (0.9%Sodium chloride). For groups 1 and 2, sham PDT will be performed by directing the Light cure device without turning on the light beam.

Sponsors

University of Mysore
CollaboratorOTHER
KLE Society's Institute of Dental Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

This is a Split Mouth Double Blind Randomized Controlled Clinical Trial in which both participants and care provider are blinded.

Intervention model description

16 patients contributing a total of 64 sites will be selected. Recording of clinical and microbiological parameters will be done at baseline, end of 1 month, and 3 months. Oral hygiene instructions will be given. Following full mouth SRP, each quadrant will be randomly assigned by simple randomization using a computer generated randomization technique into one of the following four treatment modalities. Group 1 (control) - Application of placebo gel followed by sham PDT (Directing the Light cure device without turning on the light beam). Group 2 -Application of Zinc oxide gel followed by sham PDT. Group 3 - Application of placebo gel followed by PDT. Group 4 - Application of Zinc oxide gel followed by PDT. The procedure mentioned for each group will be performed on all periodontal pockets in the assigned quadrant at baseline, end of 1 week and 1 month from the first session. Study period - 3 months

Eligibility

Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients of both genders diagnosed with chronic periodontitis in the age group of 30 to 50 years with good systemic health. * Presence of a minimum of 20 teeth and at least one site with probing pocket depth (PPD) of 4-7 mm and clinical attachment level (CAL) of 2 mm or greater, in each of the four quadrants.

Exclusion criteria

* Patients who have undergone periodontal therapy during the previous 6 months of commencement of the study. * Subjects on antibiotics or immunosuppressant medication 6 months prior to the study. * Chronic Smokers, Alcoholics, Smokeless tobacco users. * Subjects with acute illnesses/acute intraoral lesions. * Pregnant women and lactating mothers. * Medically compromised subjects.

Design outcomes

Primary

MeasureTime frameDescription
Change in Microbial profile3 monthsChange in levels of P.gingivalis following PDT

Secondary

MeasureTime frameDescription
Change in Plaque index score3 monthsChange in plaque index score from Range: 2-3 to Range: 0 to1.9 following PDT
Change in Gingival index score3 monthsChange in Gingival index score from Range: 2-3 to Range: 0 to1.9 following PDT
Probing pocket depth3 monthsChange in probing pocket depth from 5-7 mm to 2.9- 4.2 mm following PDT
Clinical attachment level3 monthsGain in clinical attachment level following PDT

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026